 NEW YORK, July 1, 2021 PRNewswire -- Orion Biotech Opportunities Corp. Nasdaq: ORIAU the Company or us announced that, commencing July 2, 2021, holders of the units sold in the Companys initial public offering of 20,000,000 units, completed on May 17, 2021, may elect to separately trade the Class A ordinary shares and warrants included in the units. Those units that are not separated at the election of the holder will continue to trade on the Nasdaq Stock Market LLC Nasdaq under the symbol ORIAU, and the Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols ORIA and ORIAW, respectively. 